|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$7,390,233
|
N/A
|
National Institutes of Health
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$232,286
|
N/A
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$4,800
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$2,400
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$4,746
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$7,982
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$151,709
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112-00377
|
$254,770
|
$191,077
|
Abnet, Christian
|
DCEG (NCI)
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
2R01CA140368-06
|
$369,313
|
$369,313
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
3R01CA195708-04S1
|
$94,087
|
$94,087
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-04
|
$382,753
|
$382,753
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-17
|
$244,074
|
$48,815
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
5K22CA181550-03
|
$162,000
|
$162,000
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$476,711
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$226,753
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-04
|
$544,710
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-05
|
$2,680,381
|
$1,340,191
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-03
|
$610,389
|
$610,389
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Aspirin Metabolomics in Colorectal Cancer Chemoprevention
|
5R01CA188038-03
|
$441,330
|
$441,330
|
BARRY, ELIZABETH
|
DARTMOUTH COLLEGE
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
$91,727
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Dopamine as a therapeutic agent in stomach cancer
|
5R01CA169158-05
|
$319,550
|
$159,775
|
BASU, SUJIT
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
$2,498
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
$1,233
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
$461
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
$600
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
$1,136
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S6
|
$75,709
|
$757
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S7
|
$75,000
|
$750
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S8
|
$166,146
|
$1,661
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$22,850
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
RNF128 Regulation of TP53 in Barrett's Progression
|
1R01CA215596-01
|
$414,063
|
$136,641
|
BEER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-04
|
$778,686
|
$778,686
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Ovarian Cancer Chemoprevention
|
5R01CA196200-03
|
$500,225
|
$500,225
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Targeting HPV Consequences in a Cervical Cancer Clinical Trial
|
5R01CA200126-02
|
$425,061
|
$425,061
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$1,800
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-45
|
$5,113,872
|
$664,803
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Colon Cancer Chemoprevention with Phosphodiesterase-5 Inhibitors
|
5R01CA172627-05
|
$311,250
|
$311,250
|
BROWNING, DARREN
|
AUGUSTA UNIVERSITY
|
|
SPORE in Lung Cancer
|
3P50CA058187-22S1
|
$61,337
|
$30,669
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
SPORE in Lung Cancer
|
5P50CA058187-22
|
$2,300,000
|
$1,150,000
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA016058-41S1
|
$139,874
|
$5,595
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S2
|
$125,000
|
$5,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S3
|
$200,000
|
$8,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-41
|
$5,040,816
|
$201,633
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
|
5R01CA185301-03
|
$352,275
|
$352,275
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Oncology Training Grant
|
5T32CA009338-39
|
$514,824
|
$257,412
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Nutrition, Biostatistics & Bioinformatics Training Grant
|
5T32CA090301-17
|
$67,733
|
$16,933
|
CARROLL, RAYMOND
|
TEXAS A&M UNIVERSITY
|
|
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target
|
3R01CA204345-02S1
|
$94,709
|
$94,709
|
CASERO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target
|
5R01CA204345-02
|
$640,484
|
$640,484
|
CASERO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Inflammation and Colorectal Neoplasia
|
5R01CA137178-08
|
$755,127
|
$755,127
|
CHAN, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Chemoprevention for this search: $96,073,986
|